Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Flourishing in Retirement: Individual Accounts of Post-Profession Satisfaction - 2'We were genuinely astonished': This moss survived 9 months outside the International Space Station and could still grow on Earth
- 3Step by step instructions to Pick the Right Dental specialist for Your Teeth Substitution
- 4Katz alleges Army Radio workers misled High Court in bid to halt closure
- 5'People We Meet on Vacation' is the 1st of many Emily Henry adaptations: What other books turned movies to look forward to
- Father and son spending Christmas together after health scares
- Tech Development Disclosed: A Survey of \Usefulness and Configuration in Concentration\ Tech Item
- Rediscovering Experience Through Excursions: Individual Travel Stories
- Genetic study identifies earliest-known dog, dating to 15,800 years ago
- Russia confirms 16 Cameroonian soldiers killed in Ukraine war
- 'The Beast in Me' arrives on Netflix: Is it based on a true story? And what drew Claire Danes to it? What to know about the thriller series.
- After fleeing past Hezbollah fighting, some Israelis on northern border vow to stay
- Esteem Stuffed Gaming Workstations to Consider
- The cave was pitch black – so to create this magical underwater shot, the photographer had to use all his camera expertise...
